47 results on '"Pintó, X."'
Search Results
2. Genetic risk score of hypertiglyceridemia and its interaction with clinical variants
3. SEA 2022 standards for the comprehensive control of cardiovascular risk
4. Clínica e Investigación en Arteriosclerosis, la revista Iberoamericana de lipidologia y riesgo vascular
5. Clinica e investigación en Arteriosclerosis, the Iberoamerican Journal of Lipidology and vascular risk
6. Relationship between five genetic variants and the variability of hypertriglyceridemia
7. Long-term effects of PCSK9I on lipid profile and goal attainment in high cardiovascular risk patients from a real-world clinical setting
8. Health-related quality of life in individuals with metabolic syndrome: A cross-sectional study
9. Longitudinal changes in Mediterranean diet and transition between different obesity phenotypes
10. Nuevas perspectivas en el tratamiento de la hipercolesterolemia desde la disponibilidad de los inhibidores de la proteína PCSK9
11. Mediterranean alcohol-drinking pattern, low to moderate alcohol intake and risk of atrial fibrillation in the PREDIMED study
12. Fermented dairy products, diet quality, and cardio–metabolic profile of a Mediterranean cohort at high cardiovascular risk
13. Relationship between adherence to the mediterranean diet and frailty criteria in a cohort of patients with metabolic syndrome: predimed plus study
14. Egg consumption and cardiovascular disease according to diabetic status: The PREDIMED study
15. The PREDIMED trial, Mediterranean diet and health outcomes: How strong is the evidence?
16. Chronic kidney disease and dyslipidaemia
17. Epidemiological Burden and Management of Hypercholesterolemia in High Cardiovascular Risk Patients in Spain: a Comprehensive Picture from a Systematic Review of the Literature
18. Cardiometabolic risk related with the association of hypertriglyceridemia and low HDL cholesterol levels
19. Does the Mediterranean diet counteract the adverse effects of abdominal adiposity?
20. Atherogenic dyslipidemia: prevalence and management in lipid clinics
21. Dislipemia aterogénica: prevalencia y control en las unidades de lípidos
22. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study
23. Mediterranean diet and heart rate: The PREDIMED randomised trial
24. Dietary intake and major food sources of polyphenols in a Spanish population at high cardiovascular risk: The PREDIMED study
25. Relationship between dietary glycemic index, dietary glycemic load and major cardiovascular events in the PREDIMED study
26. El largo trecho para llegar a los objetivos en el tratamiento de las dislipemias
27. Predictores de adhesión a tratamiento dietético: experiencia del PREDIMED
28. ¿Debe modificarse el tratamiento de la dislipidemia diabética después del estudio ACCORD?
29. Fármacos establecidos para elevar el colesterol unido a lipoproteínas de alta densidad: ¿puede haber diferencias en los mecanismos y en los beneficios?
30. Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio. Recomendaciones del foro HDL. Resumen ejecutivo
31. Controversia terapéutica: clopidogrel y estatinas
32. Efectos inmunomoduladores de las estatinas
33. Tratamiento de la dislipemia diabética con fármacos hipolipemiantes. Nuevos conceptos
34. Importancia del colesterol ligado a lipoproteínas de alta densidad (cHDL) en la prevención del riesgo cardiovascular. Recomendaciones del Foro HDL
35. Control lipídico en prevención secundaria: estudio multicéntrico, observacional en atención primaria
36. Efecto de diferentes polimorfismos en el gen del OATP-C sobre la respuesta hipolipemiante al tratamiento con pravastatina
37. Calcificación arterial prematura de las arterias poplítea y tibial
38. Cálculo del riesgo cardiovascular
39. Homocisteinemia total y deterioro cognitivo en pacientes con diabetes tipo 2
40. Mejoría de la disfunción endotelial en individuos con hipercolesterolemia moderada y enfermedad coronaria tratados con pravastatina
41. The hospital de bellvitge atherosclerosis secondary preventive program. Main results and predictors of clinical course
42. A rare Apo E variant, Apo E3 ΔL149, associated with familial hypercholesterolemia
43. Aspects of endothelial function in visceral obesity
44. 2.P.237 Cardiovascular risk factors in peripheral arterial disease patients with and without previous history of coronary artery disease
45. 2.P.238 Moderate hyperhomocysteinemia and early myocardial infarction: Relation with vitamins B6, B12 and folate
46. 4.P.259 Disorders of lipoprotein metabolism in active sarcoidosis
47. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.